• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于肝细胞癌识别的基于血液的22基因表达特征。

A blood-based 22-gene expression signature for hepatocellular carcinoma identification.

作者信息

Zheng Jie, Zhu Ming-Yu, Wu Fei, Kang Bin, Liang Ji, Heskia Fabienne, Shan Yun-Feng, Zhang Xin-Xin

机构信息

Department of Interventional Radiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.

Department of Gastroenterology, Ruijin Hospital North, School of Medicine, Shanghai Jiao Tong University, Shanghai 201800, China.

出版信息

Ann Transl Med. 2020 Mar;8(5):195. doi: 10.21037/atm.2020.01.93.

DOI:10.21037/atm.2020.01.93
PMID:32309342
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7154425/
Abstract

BACKGROUND

Hepatocellular carcinoma (HCC) is one of the most common and lethal malignancies. Early detection of HCC could largely reduce mortalities. Ultrasonography (US) and serum Alpha Fetoprotein (AFP) test are the screening methods that are most frequently applied to high-risk populations. Due to the poor performance of AFP testing, and the highly operator-dependent nature of US, a biomarker for HCC early diagnosis is highly sought after. We developed a method for HCC screening using a 22-gene expression signature.

METHODS

Peripheral whole blood of 98 patients were processed through microarrays for the first round of feature selection via two strategies, Minimal Redundancy Maximal Relevance and Least Absolute Shrinkage and Selection Operator combined with Support Vector Machine (SVM). Candidate genes were combined for further validation through qPCR in an enlarged population with 316 samples with 104 chronic hepatitis, 112 liver cirrhosis (LC), and 100 HCC.

RESULTS

A 22-gene signature was established in classifying HCC and non-cancer samples with good performance. The area under curve reached 0.94 in all of the samples and 0.93 in the AFP -negative samples.

CONCLUSIONS

We have established a blood mRNA signature with high performance for HCC screening. Our results show transcriptome of peripheral blood could be valuable source for biomarkers.

摘要

背景

肝细胞癌(HCC)是最常见且致命的恶性肿瘤之一。早期检测肝细胞癌可大幅降低死亡率。超声检查(US)和血清甲胎蛋白(AFP)检测是最常用于高危人群的筛查方法。由于AFP检测效果不佳,且超声检查高度依赖操作者,因此迫切需要一种用于肝细胞癌早期诊断的生物标志物。我们开发了一种利用22个基因表达特征进行肝细胞癌筛查的方法。

方法

对98例患者的外周全血进行微阵列处理,通过最小冗余最大相关和最小绝对收缩与选择算子结合支持向量机(SVM)这两种策略进行第一轮特征选择。将候选基因组合起来,通过qPCR在一个扩大的人群中进一步验证,该人群包括316个样本,其中有104例慢性肝炎、112例肝硬化(LC)和100例肝细胞癌。

结果

建立了一个22个基因的特征,用于对肝细胞癌和非癌样本进行分类,性能良好。在所有样本中曲线下面积达到0.94,在AFP阴性样本中达到0.93。

结论

我们建立了一种用于肝细胞癌筛查的高性能血液mRNA特征。我们的结果表明外周血转录组可能是生物标志物的宝贵来源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e43/7154425/4b224d359129/atm-08-05-195-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e43/7154425/a2e01b01fc57/atm-08-05-195-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e43/7154425/e3b7714e3768/atm-08-05-195-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e43/7154425/4b224d359129/atm-08-05-195-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e43/7154425/a2e01b01fc57/atm-08-05-195-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e43/7154425/e3b7714e3768/atm-08-05-195-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e43/7154425/4b224d359129/atm-08-05-195-f3.jpg

相似文献

1
A blood-based 22-gene expression signature for hepatocellular carcinoma identification.一种用于肝细胞癌识别的基于血液的22基因表达特征。
Ann Transl Med. 2020 Mar;8(5):195. doi: 10.21037/atm.2020.01.93.
2
Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein marker.基于 SELDI-TOF 蛋白组指纹图谱和甲胎蛋白标志物联合检测对早期肝细胞癌的增强探测。
Ann Surg Oncol. 2010 Sep;17(9):2518-25. doi: 10.1245/s10434-010-1038-8. Epub 2010 Mar 31.
3
Diagnostic value of 5 serum biomarkers for hepatocellular carcinoma with different epidemiological backgrounds: A large-scale, retrospective study.5 种血清生物标志物对不同流行病学背景肝细胞癌的诊断价值:一项大规模、回顾性研究。
Cancer Biol Med. 2021 Feb 15;18(1):256-270. doi: 10.20892/j.issn.2095-3941.2020.0207.
4
[Differential analysis of gene expression profiles in hepatocellular carcinoma patients with high and low levels of alpha-fetoprotein].[甲胎蛋白高低水平的肝细胞癌患者基因表达谱的差异分析]
Zhonghua Zhong Liu Za Zhi. 2020 May 23;42(5):396-402. doi: 10.3760/cma.j.cn112152-112152-20191115-00740.
5
Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis.在非病毒性肝硬化患者中,利用血清甲胎蛋白检测和腹部超声进行肝细胞癌筛查比单纯使用超声更有效。
J Gastrointest Cancer. 2018 Dec;49(4):476-480. doi: 10.1007/s12029-017-0006-y.
6
Serum peptide pattern that differentially diagnoses hepatitis B virus-related hepatocellular carcinoma from liver cirrhosis.用于鉴别诊断乙肝病毒相关性肝细胞癌与肝硬化的血清肽谱。
J Gastroenterol Hepatol. 2014;29(7):1544-50. doi: 10.1111/jgh.12545.
7
A blood-based three-gene signature for the non-invasive detection of early human hepatocellular carcinoma.基于血液的三个基因标志物用于早期人肝细胞癌的非侵入性检测。
Eur J Cancer. 2014 Mar;50(5):928-36. doi: 10.1016/j.ejca.2013.11.026. Epub 2013 Dec 11.
8
Identification and Analysis of the Blood lncRNA Signature for Liver Cirrhosis and Hepatocellular Carcinoma.肝硬化和肝细胞癌血液lncRNA特征的鉴定与分析
Front Genet. 2020 Dec 7;11:595699. doi: 10.3389/fgene.2020.595699. eCollection 2020.
9
Urine α-fetoprotein and orosomucoid 1 as biomarkers of hepatitis B virus-associated hepatocellular carcinoma.尿液甲胎蛋白和血清黏蛋白 1 作为乙型肝炎病毒相关性肝细胞癌的生物标志物。
Am J Physiol Gastrointest Liver Physiol. 2020 Feb 1;318(2):G305-G312. doi: 10.1152/ajpgi.00267.2019. Epub 2019 Nov 18.
10
A Large-scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma.一项用于肝细胞癌早期检测的大规模、多中心血清代谢物生物标志物鉴定研究。
Hepatology. 2018 Feb;67(2):662-675. doi: 10.1002/hep.29561. Epub 2018 Jan 2.

引用本文的文献

1
Current Situation and Prospects of Digital Therapeutics in the Field of Liver Diseases in China.中国肝脏疾病领域数字疗法的现状与展望
Adv Ther. 2025 Jun;42(6):2639-2658. doi: 10.1007/s12325-024-03086-3. Epub 2025 Apr 18.
2
Transcriptomics of MASLD Pathobiology in African American Patients in the Washington DC Area .华盛顿特区非裔美国人中 MASLD 发病机制的转录组学研究。
Int J Mol Sci. 2023 Nov 23;24(23):16654. doi: 10.3390/ijms242316654.
3
LncRNA SATB2-AS1 overexpression represses the development of hepatocellular carcinoma through regulating the miR-3678-3p/GRIM-19 axis.

本文引用的文献

1
Degradation of CCNB1 mediated by APC11 through UBA52 ubiquitination promotes cell cycle progression and proliferation of non-small cell lung cancer cells.由APC11通过UBA52泛素化介导的CCNB1降解促进非小细胞肺癌细胞的细胞周期进程和增殖。
Am J Transl Res. 2019 Nov 15;11(11):7166-7185. eCollection 2019.
2
BRD4 and Cancer: going beyond transcriptional regulation.BRD4 与癌症:超越转录调控。
Mol Cancer. 2018 Nov 22;17(1):164. doi: 10.1186/s12943-018-0915-9.
3
Downregulation of Dock1 and Elmo1 suppresses the migration and invasion of triple-negative breast cancer epithelial cells through the RhoA/Rac1 pathway.
长链非编码RNA SATB2-AS1的过表达通过调控miR-3678-3p/GRIM-19轴抑制肝细胞癌的发展。
Cancer Cell Int. 2023 Apr 28;23(1):82. doi: 10.1186/s12935-023-02901-1.
4
Repressing phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma by microRNA-142-3p restrains the progression of hepatocellular carcinoma.微小 RNA-142-3p 抑制磷脂酰肌醇-4,5-二磷酸 3-激酶催化亚基 γ,从而抑制肝癌的进展。
Bioengineered. 2022 Jan;13(1):1491-1506. doi: 10.1080/21655979.2021.2020549.
5
New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma.用于诊断甲胎蛋白阴性肝细胞癌的新型血液生物标志物
Front Oncol. 2020 Aug 14;10:1316. doi: 10.3389/fonc.2020.01316. eCollection 2020.
Dock1和Elmo1的下调通过RhoA/Rac1途径抑制三阴性乳腺癌上皮细胞的迁移和侵袭。
Oncol Lett. 2018 Sep;16(3):3481-3488. doi: 10.3892/ol.2018.9077. Epub 2018 Jul 4.
4
The Platelet Lifeline to Cancer: Challenges and Opportunities.血小板与癌症的生命线:挑战与机遇。
Cancer Cell. 2018 Jun 11;33(6):965-983. doi: 10.1016/j.ccell.2018.03.002. Epub 2018 Apr 12.
5
Identification of genomic aberrations associated with lymph node metastasis in diffuse-type gastric cancer.鉴定弥漫型胃癌淋巴结转移相关的基因组异常。
Exp Mol Med. 2018 Apr 6;50(4):1-11. doi: 10.1038/s12276-017-0009-6.
6
A Blood RNA Signature Detecting Severe Disease in Young Dengue Patients at Hospital Arrival.入院时血液 RNA 标志物可用于检测重症登革热患儿
J Infect Dis. 2018 May 5;217(11):1690-1698. doi: 10.1093/infdis/jiy086.
7
Analysis of blood-based gene expression in idiopathic Parkinson disease.特发性帕金森病血液基因表达分析
Neurology. 2017 Oct 17;89(16):1676-1683. doi: 10.1212/WNL.0000000000004516. Epub 2017 Sep 15.
8
Unbiased Identification of Blood-based Biomarkers for Pulmonary Tuberculosis by Modeling and Mining Molecular Interaction Networks.通过建模和挖掘分子相互作用网络无偏鉴定肺结核的血液生物标志物
EBioMedicine. 2017 Feb;15:112-126. doi: 10.1016/j.ebiom.2016.12.009. Epub 2016 Dec 21.
9
How useful is thrombocytosis in predicting an underlying cancer in primary care? a systematic review.血小板增多症在基层医疗中预测潜在癌症的作用有多大?一项系统综述。
Fam Pract. 2017 Feb;34(1):4-10. doi: 10.1093/fampra/cmw100. Epub 2016 Sep 28.
10
Blood-based gene expression profiling in castrate-resistant prostate cancer.去势抵抗性前列腺癌的血液基因表达谱分析
BMC Med. 2015 Sep 14;13:219. doi: 10.1186/s12916-015-0463-8.